"Lead, follow, or get out of the way." This is one of those well-known aphorisms that's been around forever -...
It was the very first stock that I recommended on the very first day we published Private Briefing nearly eight years ago...
I've...
Our new list of best stocks to buy now features a few Money Morning all-stars riding new catalysts.
Plus, we've got a couple newcomers...
One of the biggest waves in healthcare now is the care and treatment of the aging population. Among the more common maladies we face as we get...
Our Bill Patalon first introduced this biotech company to you on the very first day he published his Private Briefing service, and it's been a...
Our latest list of stocks to watch now includes the world's largest fast-food chain expanding in China, our top-performing stock pick advancing a...
Here at Money Morning, we work with a team of 11 investing and market professionals who've invested real money for themselves and others over the...
Biotech stocks in 2017 are beating the markets with nearly double the gains of the Dow. And the biotech sector is expected to continue beating the...
Insys Therapeutics - our "War on Pain" biotech play - has given us a profit of more than 10.7% since we recommended the stock a little less than...
We've talked about the stellar "Baby Biotech" I'm going to update you on today. It's actually the first stock I ever recommended in Private...
Some of the best stocks to buy now have already logged impressive gains.
These are stocks that keep rising higher over time. While many...
When markets fall, the best stocks to buy right now will not get hit as badly as the broader index. That's because healthy companies can see share...
This was the very first stock we recommended on the very first day Private Briefing was published - Aug. 11, 2011.
On that day, you...